Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2026 | 06-2025 | 06-2024 | 06-2023 | 06-2022 | |
| Sales | 1,215,039 | 1,219,635 | 1,159,060 | 1,136,702 | 1,105,599 |
| Cost of Goods | 415,968 | 429,363 | 389,335 | 366,887 | 349,103 |
| Gross Profit | 799,071 | 790,272 | 769,725 | 769,815 | 756,496 |
| Operating Expenses | 548,149 | 688,380 | 563,374 | 471,758 | 460,009 |
| Operating Income | 251,890 | 102,255 | 206,686 | 298,944 | 296,590 |
| Interest Expense | 9,630 | 8,509 | 15,736 | 11,215 | 11,309 |
| Other Income | -1,580 | 4,717 | -5,261 | 50,930 | 16,105 |
| Pre-tax Income | 240,680 | 98,463 | 185,689 | 338,659 | 301,386 |
| Income Tax | 58,818 | 25,063 | 17,584 | 53,217 | 38,287 |
| Net Income Continuous | 181,862 | 73,400 | 168,105 | 285,442 | 263,099 |
| Minority Interests | N/A | N/A | N/A | 179 | -8,952 |
| Net Income | $181,862 | $73,400 | $168,105 | $285,263 | $272,051 |
| EPS Basic Total Ops | 1.17 | 0.47 | 1.07 | 1.81 | 1.73 |
| EPS Basic Continuous Ops | 1.17 | 0.47 | 1.07 | 1.82 | 1.68 |
| EPS Diluted Total Ops | 1.16 | 0.46 | 1.05 | 1.76 | 1.66 |
| EPS Diluted Continuous Ops | 1.16 | 0.46 | 1.05 | 1.76 | 1.60 |
| EPS Diluted Before Non-Recurring Items | 1.72 | 1.71 | 1.57 | 1.79 | 1.75 |
| EBITDA(a) | $349,249 | $212,158 | $318,397 | $406,182 | $397,659 |